Evidence map›Paper›PMID 36419154›Full record

ArticleMicrobial cell factories2022

Biological activity of new bioactive steroids deriving from biotransformation of cortisone.

Stefania Costa, Paola Tedeschi, Luca Ferraro, Sarah Beggiato, Alessandro Grandini, Stefano Manfredini, Raissa Buzzi, Gianni Sacchetti, Giuseppe Valacchi

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 3 countries.

Stefania Costa *Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via L. Borsari, 46 Ferrara, 44121, Ferrara, Italy. stefania.costa@unife.it.
Paola Tedeschi *Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via L. Borsari, 46 Ferrara, 44121, Ferrara, Italy.
Luca FerraroDepartment of Life Sciences and Biotechnology, University of Ferrara, Via L. Borsari, 46 Ferrara, 44121, Ferrara, Italy.
Sarah BeggiatoDepartment of Life Sciences and Biotechnology, University of Ferrara, Via L. Borsari, 46 Ferrara, 44121, Ferrara, Italy.
Alessandro GrandiniDepartment of Life Sciences and Biotechnology, University of Ferrara, Via L. Borsari, 46 Ferrara, 44121, Ferrara, Italy.
Stefano ManfrediniDepartment of Life Sciences and Biotechnology, University of Ferrara, Via L. Borsari, 46 Ferrara, 44121, Ferrara, Italy.
Raissa BuzziDepartment of Life Sciences and Biotechnology, University of Ferrara, Via L. Borsari, 46 Ferrara, 44121, Ferrara, Italy.
Gianni SacchettiDepartment of Life Sciences and Biotechnology, University of Ferrara, Via L. Borsari, 46 Ferrara, 44121, Ferrara, Italy.
Giuseppe ValacchiDepartment of Environmental Sciences and Prevention, University of Ferrara, Via L. Borsari, 46 Ferrara, 44121, Ferrara, Italy.
University of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cortisone is a metabolite belonging to the corticosteroid class that is used pharmaceutically directly as a drug or prodrug. In addition to its large consumption, its use is linked to several side effects, so pharmaceutical research aims to develop effective drugs with low or no side effects, alternative compounds to cortisone are part of an active investment in ongoing research on drug discovery. Since biotransformation can be considered a source of new molecules with potential therapeutic use, the present work focuses on a preliminary in vitro study aimed at evaluating the mutagenic, anti-inflammatory, antioxidant and neuroprotective activity of SCA and SCB molecules obtained from the biotransformation of cortisone using Rh. Rhodnii strain DSM 43960. The results obtained are very encouraging due to the safety of biotransformed compounds with reference to genotoxicity checked by Ames test, to the very high antioxidant capacity and to the anti-inflammatory activity. In fact, thecompounds inhibited both the TNFα-stimulated expression and secretion of NFkB target cytokines, and COX activity, and can activate the glucocorticoid receptor. Finally SCA and SCB exhibited neuroprotective properties.

Indexed as

CortisoneAnti-Inflammatory AgentsAntioxidantsBiotransformationSteroidsAnti-Inflammatory AgentsAntioxidantsCortisoneSteroidsAnti-inflammatoryAntioxidantBiotransformationsCortisoneNeuroprotectiveSteroids

Identifiers

PMID36419154
PMCPMC9685055
OpenAlexW4309924001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.